News from Intrexon Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 25, 2016, 08:00 ET Intrexon Introduces Florian™ Switch Technology for Flowering Control

 Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of...


Jun 30, 2016, 16:01 ET Intrexon Appoints Fred Hassan, Distinguished Life Sciences Executive, to Board of Directors

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Fred Hassan to its Board of Directors,...


Jun 28, 2016, 09:51 ET INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intrexon Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 - XON

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities...


Jun 20, 2016, 08:00 ET Intrexon to Present at the JMP Securities Life Sciences Conference

GERMANTOWN, Md., June 20, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announces Geno Germano, President...


Jun 06, 2016, 13:12 ET INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON

 The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on...


Jun 06, 2016, 08:00 ET Intrexon Announces Retirement of Samuel Broder, M.D., Head of Health Sector

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the retirement of Samuel Broder, M.D., Senior Vice President...


May 31, 2016, 15:21 ET Oxitec extiende la solución de control de vectores en Brasil

Oxitec y el Ayuntamiento de Piracicaba han completado hoy la expansión del "Proyecto del Aedes aegypti Amigable", que ha durado varios...


May 23, 2016, 08:00 ET Intrexon to Present at Upcoming Investor and Industry Conferences

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it will present at the following upcoming investor...


May 17, 2016, 08:00 ET Intrexon Appoints Geno Germano to New Role of President

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Geno Germano to the new role of...


May 16, 2016, 09:11 ET Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws

The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation...


May 13, 2016, 14:50 ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline - XON

 Pomerantz LLP announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company") (NYSE: XON) and...


May 10, 2016, 16:05 ET Intrexon Announces First Quarter 2016 Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its first quarter results for 2016.  Business...


May 09, 2016, 20:47 ET Lifshitz & Miller Law Firm Announces Investigation of Amaya, Inc., Chiasma, Inc., Intrexon Corporation, Natus Medical Inc., NRG Yield, Inc., Sunrun Inc., TransEnterix and Vivint Solar, Inc.

Amaya, Inc. (AYA) Lifshitz & Miller  announces investigation on behalf of Amaya investors.  Specifically, on March 23, 2016, news...


May 04, 2016, 10:00 ET DEADLINE ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intrexon Corporation (XON) and Lead Plaintiff Deadline: July 5, 2016

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Intrexon Corporation ("Intrexon" or "the...


May 04, 2016, 08:30 ET Intrexon Establishes Crop Protection Enterprise

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the formation of Intrexon Crop Protection (ICP), a...


May 03, 2016, 18:25 ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intrexon Corporation - XON

 Pomerantz LLP is investigating claims on behalf of investors of Intrexon Corporation ("Intrexon" or the "Company") (NYSE: XON).  Such...


Apr 28, 2016, 08:00 ET Intrexon to Announce First Quarter 2016 Financial Results on May 10th

 Intrexon Corporation (NYSE: XON) today announced it will release first quarter 2016 financial results after the market closes on Tuesday, May...


Apr 26, 2016, 15:45 ET Wolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in Intrexon Corporation

Wolf Popper LLP is investigating potential securities fraud claims on behalf of investors in Intrexon Corporation (NYSE: XON), resulting from a...


Apr 25, 2016, 11:45 ET SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Intrexon Corporation (XON)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of...


Apr 22, 2016, 13:08 ET Harwood Feffer LLP Announces Investigation of Intrexon Corporation

 Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Intrexon Corporation ("Intrexon" or the...


Apr 22, 2016, 07:15 ET Intrexon Provides Update on Recent Stock Trading Activity

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, provided an update to its shareholders regarding recent trading activity in...


Apr 04, 2016, 08:00 ET Intrexon Forms Collaboration to Develop Treatment for Type 1 Diabetes

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the formation of Intrexon T1D Partners, LLC, a joint venture...


Mar 30, 2016, 08:00 ET Intrexon Pilot Plant for its Methanotroph Bioconversion Platform Now Operational

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the pilot plant for its proprietary gas-to-liquids...


Mar 21, 2016, 06:45 ET Intrexon Realigns Responsibilities, Augments Team

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced a realignment of management responsibilities in response to...


Feb 29, 2016, 16:05 ET Intrexon Announces Fourth Quarter and Full Year 2015 Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its fourth quarter and full year results for 2015. ...